Ligands of the peroxisome proliferator-activated receptor-gamma and heart failure.

Br J Pharmacol

The Department of Experimental Medicine, Nephrology and Critical Care, William Harvey Research Institute, St Bartholomew's and The Royal London School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ.

Published: January 2004

Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor superfamily of ligand-activated transcription factors that are related to retinoid, steroid and thyroid hormone receptors. The PPAR subfamily comprises of three members, PPAR-alpha, PPAR-beta and PPAR-gamma. There is good evidence that ligands of PPAR-gamma, including certain thiazolinediones, reduce myocardial tissue injury and infarct size. The use of PPAR-gamma agonists in the treatment of heart failure is, however, controversial.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574172PMC
http://dx.doi.org/10.1038/sj.bjp.0705586DOI Listing

Publication Analysis

Top Keywords

peroxisome proliferator-activated
8
heart failure
8
ligands peroxisome
4
proliferator-activated receptor-gamma
4
receptor-gamma heart
4
failure peroxisome
4
proliferator-activated receptors
4
receptors ppars
4
ppars members
4
members nuclear
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!